IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants
View Patent ↗The present invention provides an improved coating for surfaces of medical implants. The coating comprises at least one interfacial biomaterial (IFBM) which is comprised of at least one binding module that binds to the surface of an implant or implant-related material (“implant module”) and at least one binding module that selectively binds to a target analyte or that is designed to have a desired effect (“analyte module”). The modules are connected by a linker. In some embodiments, the IFBM coating acts to promote the recognition and attachment of target analytes to surface of the device. The IFBM coating improves the performance of implanted medical devices, for example, by promoting osteointegration of the implant.
1. A binding module comprising a polypeptide having a sequence set forth in SEQ ID NO: 72, or a conservatively substituted variant thereof, wherein the binding module binds to a bone morphogenetic protein.
2. The binding module of claim 1 , wherein the bone morphogenetic protein is bone morphogenetic protein-2.
3. An interfacial biomaterial coating for an implant, the coating comprising:
a. at least one binding module comprising a polypeptide that binds to the surface of an implant; and
b. at least one binding module that binds to a bone morphogenetic protein, wherein the bone morphogenetic protein binding module comprises a polypeptide having a sequence motif set forth in SEQ ID NO: 72, or a conservatively substituted variant thereof,
wherein the surface binding module and the bone morphogenetic protein binding module are linked and can be modified to comprise one or more terminal modifications and a modification to facilitate the linking.
4. The coating of claim 3 , wherein the implant comprises a material selected from the group consisting of a polymer, a collagen, a demineralized bone matrix, a ceramic, a plastic, a metal, a titanium alloy, and a zirconium oxide.
5. The coating of claim 3 , wherein the linker is selected from the group consisting of bonds of the polypeptides to be linked, an amino acid linker, a polymer linker, and a chemical linker.
6. The coating of claim 3 , wherein the bone morphogenetic protein is bone morphogenetic protein-2.
7. The coating of claim 3 , wherein the implant comprises collagen and the bone morphogenetic protein is bone morphogenetic protein-2.
8. The coating of claim 3 , wherein the implant comprises demineralized bone matrix and the bone morphogenetic protein is bone morphogenetic protein-2.
9. A binding module comprising a polypeptide having at least 75% sequence identity to SEQ ID NO: 72, wherein the binding module binds to a bone morphogenetic protein.
10. A method for coating an implant, the method comprising contacting an interfacial biomaterial coating with the implant, the interfacial biomaterial coating comprising:
a. at least one binding module comprising a polypeptide that binds to the surface of an implant; and
b. at least one binding module that binds to a bone morphogenetic protein, wherein the bone morphogenetic protein binding module comprises a polypeptide having a sequence motif set forth in SEQ ID NO: 72, or a conservatively substituted variant thereof,
wherein the surface binding module and the bone morphogenetic protein binding module are linked and can be modified to comprise one or more terminal modifications and a modification to facilitate the linking.
11. The method of claim 10 , wherein the implant comprises a material selected from the group consisting of a polymer, a collagen, a demineralized bone matrix, a ceramic, a plastic, a metal, a titanium alloy, and a zirconium oxide.
12. The method of claim 10 , wherein the linker is selected from the group consisting of bonds of the polypeptides to be linked, an amino acid linker, a polymer linker, and a chemical linker.
13. The method of claim 10 , wherein the bone morphogenetic protein is bone morphogenetic protein-2.
14. The method of claim 10 , wherein the implant comprises collagen and the bone morphogenetic protein is bone morphogenetic protein-2.
15. The method of claim 10 , wherein the implant comprises demineralized bone matrix and the bone morphogenetic protein is bone morphogenetic protein-2.